|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 12-07-2004
WASHINGTON (Reuters) - U.S. health officials on Tuesday approved the importation of up to 4 million doses of influenza vaccine made by GlaxoSmithKline GSK.L GSK.N, bringing the U.S. total to 65 million vaccines for this flu season.
LONDON (Reuters) - People born in May in the northern hemisphere have a higher than average risk of developing multiple sclerosis, researchers said on Tuesday.
WASHINGTON (Reuters) - People who put on a few extra pounds may be able to blame a lack of sleep for the added weight, according to two separate studies published on Monday.
WASHINGTON (Reuters) - People who take Merck & Co. Inc.'s analgesic Vioxx are nearly three times as likely to have heart attacks as those taking Pfizer Inc.'s Celebrex, according to an independent study published on Monday.
ATLANTA (Reuters) - This year's flu season has started slowly in the United States, where there are concerns about a shortage of vaccine caused by production problems at a major manufacturer, the head of the Centers for Disease Control and Prevention said on Monday.
LOS ANGELES (Reuters) - The South Beach diet is no fad, its creator says, rejecting the notion that his eating plan would fizzle out with the rest of the low-carb craze.
NEW YORK (Reuters Health) - Since the "Back to Sleep" campaign to prevent SIDS, many babies have always slept on their backs -- but new research suggests that maybe they should be given a chance to become acquainted with being face-down, under careful observations.
LOS ANGELES (Reuters) - Users of homeopathic nasal spray Zicam Cold Remedy have filed a proposed class action lawsuit, claiming the popular over-the-counter product robbed them of their sense of smell.
NEW YORK (Reuters Health) - Treatment with Botox (botulinum-A toxin) can help women with urge incontinence, a type of urine leakage resulting from involuntary contractions of the bladder muscles, new research shows.
LOS ANGELES (Reuters) - Millennium Pharmaceuticals Inc. on Monday said studies show that its drug Velcade is effective for patients at all stages of the bone marrow cancer multiple myeloma.
|
|
